Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ze Tian

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
International Immunopharmacology|December 20, 2025
Repurposing the anesthetic dexmedetomidine: a novel antidote for sulfur mustard analog-induced acute lung injury via multi-mechanism modulationMin-Jie Shi, Jiang-Zheng Liu, Wei-Hua Yu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2010
Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1Paolo Fiorina, Mollie Jurewicz, Andrea Vergani, et al.
Cell Transplantation|March 12, 2014
TIM4 Regulates the Anti-Islet Th2 Alloimmune ResponseAndrea Vergani, Francesca Gatti, Kang M Lee, et al.
World Journal of Gastrointestinal Surgery|September 30, 2025
Impact of non-alcoholic hepatic steatosis on prognosis and clinical outcomes in gastric cancer patients undergoing laparoscopic distal gastrectomyYi-Fan Zou, Yi-Gang Zhang, Zi-Chu Zhao, et al.
Leukemia|November 30, 2023
Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALLZe Tian, Chunhua Shi, Guojun Yang, et al.
Leukemia|August 26, 2023
Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALLZe Tian, Chunhua Shi, Guojun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone diseaseAntonio Garcia-Gomez, Dalia Quwaider, Miriam Canavese, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2019
Archaic human remains from Hualongdong, China, and Middle Pleistocene human continuity and variationXiu-Jie Wu, Shu-Wen Pei, Yan-Jun Cai, et al.
Leukemia|May 28, 2025
T cell receptor mimic CAR T cells targeting cathepsin G signal peptideJun Yan, Chunhua Shi, Guojun Yang, et al.
Cancer Cell|September 15, 2012
A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistanceDharminder Chauhan, Ze Tian, Benjamin Nicholson, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
International Immunopharmacology|December 20, 2025
Repurposing the anesthetic dexmedetomidine: a novel antidote for sulfur mustard analog-induced acute lung injury via multi-mechanism modulationMin-Jie Shi, Jiang-Zheng Liu, Wei-Hua Yu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 7, 2010
Targeting the CXCR4-CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1Paolo Fiorina, Mollie Jurewicz, Andrea Vergani, et al.
Cell Transplantation|March 12, 2014
TIM4 Regulates the Anti-Islet Th2 Alloimmune ResponseAndrea Vergani, Francesca Gatti, Kang M Lee, et al.
World Journal of Gastrointestinal Surgery|September 30, 2025
Impact of non-alcoholic hepatic steatosis on prognosis and clinical outcomes in gastric cancer patients undergoing laparoscopic distal gastrectomyYi-Fan Zou, Yi-Gang Zhang, Zi-Chu Zhao, et al.
Leukemia|November 30, 2023
Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALLZe Tian, Chunhua Shi, Guojun Yang, et al.
Leukemia|August 26, 2023
Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALLZe Tian, Chunhua Shi, Guojun Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone diseaseAntonio Garcia-Gomez, Dalia Quwaider, Miriam Canavese, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2019
Archaic human remains from Hualongdong, China, and Middle Pleistocene human continuity and variationXiu-Jie Wu, Shu-Wen Pei, Yan-Jun Cai, et al.
Leukemia|May 28, 2025
T cell receptor mimic CAR T cells targeting cathepsin G signal peptideJun Yan, Chunhua Shi, Guojun Yang, et al.
Cancer Cell|September 15, 2012
A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistanceDharminder Chauhan, Ze Tian, Benjamin Nicholson, et al.
Pageof 18